The Daily Rounds: Longevity & Health Care Brief | May 10, 2026

Your daily briefing on the science of living longer, better. Covering the past 24 to 48 hours in longevity, medicine, and healthspan research.

Presented By Our Partners

🧠 NEUROLOGY & COGNITIVE HEALTH

📈 Cognitive Disability Rates in US Adults Under 40 Have Nearly Doubled Since 2013

A new study published in Neurology finds that age-adjusted self-reported cognitive disability in the US rose from 5.3% in 2013 to 7.4% in 2023, with adults aged 18 to 39 showing the steepest climb, nearly doubling from 5.1% to 9.7% over the same period. Younger adults have now overtaken older cohorts as the primary driver of overall cognitive disability prevalence, a reversal of historical trends that researchers say demands urgent investigation. Scientists are calling for study into the lifestyle, environmental, and systemic factors driving cognitive decline at earlier ages than ever recorded.

📌 Read more → Neurology

⚡ Fast and Slow Brain Signals Working Together Drive Human Thought and Cognitive Efficiency

New research reported in Neuroscience News finds that the brain blends signals operating at different timescales simultaneously, with intrinsic neural timescales shaped directly by white-matter structural pathways. Individuals whose brain wiring more closely aligned with the timescale demands of a given task showed significantly more efficient brain state transitions and stronger cognitive performance. The findings provide a new framework for understanding individual differences in information processing speed and may open fresh targets for cognitive enhancement research.

📌 Read more → Neuroscience News

❤️ CARDIOVASCULAR HEALTH

🔥 Scientific American May 2026: Chronic Inflammation Is Now Central to Heart Disease Prevention

Scientific American’s May 2026 cover story frames chronic inflammation as a primary driver of cardiovascular disease, detailing how inexpensive anti-inflammatory drugs like colchicine are entering cardiology practice as heart attack prevention tools. Research published over the past year has solidified the causal link between systemic inflammation and arterial damage, moving the field beyond cholesterol as the lone culprit. Experts argue that inflammation-first treatment protocols could prevent hundreds of thousands of cardiovascular deaths annually at minimal cost.

📌 Read more → Scientific American / PR Newswire

📱 Stanford AI Cardiac Coach Outperforms Human-Written Health Messages in Clinical Trial

Researchers at Stanford Medicine report that an AI health coaching system built around the My Heart Counts app generated cardiovascular behavior-change messages that trial participants preferred over those written by human experts. The AI was fine-tuned on the transtheoretical model of behavior change, producing highly personalized messages tailored to each user’s current stage of readiness. The results position AI-personalized coaching as a scalable tool for improving cardiovascular outcomes at the population level.

📌 Read more → Stanford Medicine

🦠 GUT MICROBIOME & IMMUNE HEALTH

🫀 AI Analysis of CT Scans Reveals Thymus Health Predicts 50% Lower Risk of Death in Adults

Two landmark studies from Mass General Brigham, published in Nature, used AI to analyze routine CT scans across more than 25,000 adults and found that those with higher thymic health scores had approximately 50% lower risk of all-cause death, 63% lower risk of cardiovascular death, and 36% lower risk of developing lung cancer. A companion study found that cancer patients with stronger thymic health had a 37% lower risk of disease progression and 44% lower risk of death during immunotherapy treatment. The findings are redirecting attention to the thymus as a modifiable longevity and immune organ in adults, not just a childhood structure.

📌 Read more → Mass General Brigham / Nature

😔 Harvard Scientists Link Gut Bacteria to Depression Through Hidden Inflammation Trigger

Researchers found that when the gut bacterium Morganella morganii interacts with a common environmental pollutant, it produces a molecule that triggers systemic inflammation strongly linked to depression. The discovery creates a mechanistic bridge between gut microbial activity, chemical exposure, and mental health that had not been previously characterized at this level of specificity. Scientists say this raises the possibility of new depression treatments targeting the gut-immune axis rather than brain chemistry alone.

📌 Read more → ScienceDaily / Harvard

🤰 Gut Microbiome Found to Train Maternal Immune Tolerance During Pregnancy

A Cornell University study found that gut microbes play a key role in training a mother’s immune system to tolerate the developing fetus, with beneficial gut bacteria helping prevent immune reactions that lead to pregnancy loss in mouse models. The findings add a new dimension to how the microbiome orchestrates systemic immune behavior, extending its documented influence from metabolic health into reproductive outcomes. Researchers say the work opens new avenues for microbiome-based interventions for pregnancy complications in humans.

📌 Read more → Cornell Chronicle

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

🔬 CELLULAR HEALTH, SENOLYTICS & EPIGENETICS

🧪 Senolytic Compounds Shown to Measurably Reduce Biological Age Markers in Blood Samples

A study published in npj Aging tested eight senolytic compounds and found that JQ1, RG7112, nutlin-3a, and AMG232 reduced epigenetic age predictions in blood samples in vitro while also decreasing expression of senescence markers SA-beta-gal and p16INK4A. The results provide proof-of-concept that senolytics can reverse measurable biological aging signatures at the cellular level, validating a core mechanism driving the anti-aging pharmaceutical field. Researchers describe the protocol as a scalable drug-screening platform for identifying next-generation senolytic candidates.

📌 Read more → npj Aging

⚙️ Geroscience Review Maps Translational Strategies for Delaying Age-Related Multimorbidity

A comprehensive review in ACS Pharmacology and Translational Science identifies the most tractable geroscience strategies for simultaneously delaying multiple age-related diseases, including senolytics, mTOR inhibition, and AI-guided molecular profiling. The authors highlight convergence between epigenetics, immunotherapy, and systems biology as the most promising direction for creating holistic anti-aging clinical interventions. The review calls for integrating precision senotherapy into standard care before multimorbidity accumulates, rather than treating individual diseases in isolation after they have developed.

📌 Read more → ACS Pharmacology & Translational Science

🤖 AI IN MEDICINE & DRUG DISCOVERY

💊 Eli Lilly Signs $2.75 Billion AI Drug Discovery Deal with Insilico Medicine

Eli Lilly announced a discovery agreement with Insilico Medicine valued at up to $2.75 billion including milestones and royalties, to bring AI-generated drug candidates to global markets across multiple disease areas. Insilico has developed at least 28 drugs using generative AI platforms, with nearly half already in clinical stages, making it one of the most prolific AI-native drug companies in the world. The deal signals that Big Pharma has moved decisively from experimenting with AI-assisted discovery to fully partnering with AI-first companies as primary R&D engines.

📌 Read more → CNBC

🔁 AI Is Reshaping Biologic Drug Discovery Across Every Major Drug Class

A deep analysis in The Medicine Maker documents how AI tools are transforming the design of biologic drugs, reducing candidate identification time from years to weeks by automating protein folding predictions, binding site analysis, and multi-compound screening simultaneously. Half of biotech companies adopting AI now report faster time-to-target identification, while 42% report measurable improvements in hit rates and scientific accuracy. The piece concludes that AI is no longer an experimental adjunct in biologics development but a core operational requirement for competitive drug pipelines.

📌 Read more → The Medicine Maker

⌚ WEARABLES, BIOMARKERS & PRECISION HEALTH

🖨️ 3D-Printed Adhesive-Free Wearable Tracks Metabolism, Dehydration, and Stress Continuously

A study published May 10 in Nature Communications from the University of Arizona describes a 3D-printed, adhesive-free wearable that monitors water vapor and skin gas emissions to continuously track physiological signals associated with dehydration, metabolic shifts, and stress levels. Unlike conventional wearables that degrade with repeated adhesive attachment and skin irritation, the new device is designed for comfortable long-term use, making it more practical for continuous monitoring across diverse populations. Researchers say the technology could transform how metabolic health is tracked outside clinical settings.

📌 Read more → University of Arizona / Nature Communications

📊 NIH All of Us Wearables Dataset Released in Nature Medicine: 59,000 Participants, 14 Years of Data

The NIH All of Us Research Program published a comprehensive wearables dataset in Nature Medicine containing Fitbit data from more than 59,000 diverse participants across 14 years, including over 39 million step observations and 31 million sleep observations. The dataset is designed to enable large-scale research on how activity, sleep, and heart rate patterns correlate with health outcomes across populations historically underrepresented in health research. Researchers say the scale and demographic diversity of the dataset make it a transformative resource for building population-level precision health models.

📌 Read more → Nature Medicine

💪 MUSCLE MASS, STRENGTH & METABOLIC HEALTH

🏃 Exercise Variety Delivers 19% Lower Premature Death Risk, Harvard 30-Year Study Finds

A Harvard study tracking more than 111,000 adults over 30 years found that people who incorporated the most varied exercise routines, including both aerobic and resistance training, had a 19% lower risk of premature death compared to those who stuck to a single activity type. Approximately 60 minutes of resistance exercise per week appeared to be the optimal threshold for mortality benefit, with diminishing returns above that volume. The findings reinforce exercise diversity, not just total activity volume, as a distinct longevity variable that warrants explicit clinical guidance.

📌 Read more → The Washington Post

⚡ Exercise Reverses Mitochondrial Dysfunction and Age-Related Muscle Decline, PNAS Study Shows

New research in PNAS provides direct evidence that age-related decline in muscle function and physical frailty are driven by mitochondrial dysfunction, and that structured exercise can reverse these impairments in both mouse models and humans. The study identifies mitochondrial remodeling in skeletal muscle as the primary mechanism through which exercise counteracts age-associated functional decline, validating exercise as mitochondrial medicine rather than a general fitness tool. Scientists say the findings have immediate implications for designing exercise prescriptions that specifically target the biology of aging muscle.

📌 Read more → PNAS

🥗 NUTRITION & METABOLIC HEALTH

⏱️ Controlled Study: Intermittent Fasting Without Calorie Reduction Shows No Measurable Metabolic Benefit

A controlled study found that time-restricted eating produced no improvements in metabolic or cardiovascular health markers when total calorie intake remained unchanged, directly challenging the popular belief that fasting windows alone deliver metabolic benefits independent of energy restriction. The timing of meals did influence the body’s internal circadian clocks, suggesting meal timing may still affect health through non-metabolic pathways. Researchers say the findings establish caloric balance, not fasting window duration, as the primary driver of metabolic improvement in time-restricted eating protocols.

📌 Read more → ScienceDaily

📋 CDC 2026 Nutrition Report Presents Reference Data for 131 Biomarkers Across the US Population

The CDC released its 2026 Nutrition Report presenting cross-sectional biomarker data from the National Health and Nutrition Examination Survey spanning 1999 to August 2023, covering 131 distinct nutritional and metabolic biomarkers across a nationally representative US population. The report establishes updated reference ranges and population-level trends in nutritional status, providing a comprehensive baseline for tracking how dietary patterns and nutritional sufficiency are shifting over time. Clinicians and researchers are expected to use the dataset to refine personalized nutrition protocols and identify high-risk deficiency patterns across demographic groups.

📌 Read more → Current Developments in Nutrition / CDC

😴 SLEEP & CIRCADIAN HEALTH

📱 Smartphone Sleep Assessments Detect Insomnia Treatment Effects More Powerfully Than Recall Questionnaires

A study from the University of Maryland School of Medicine found that real-time smartphone-based sleep assessments detected meaningful improvements in daytime insomnia symptoms, including cognitive function, fatigue, and mood, more powerfully than traditional recall questionnaires after a two-week treatment course. The real-time approach captures daily fluctuations that retrospective reporting consistently misses, making it a more sensitive instrument for evaluating both medication efficacy and behavioral sleep interventions. Researchers say this validates smartphone-based ecological momentary assessment as a superior standard for clinical sleep research going forward.

📌 Read more → University of Maryland School of Medicine

🧠 Fragmented Circadian Rhythms Linked to Faster Brain Volume Loss Over Time, Johns Hopkins Study

Johns Hopkins Bloomberg School of Public Health researchers, working with the National Institute on Aging, published findings showing that fragmented circadian rest-activity rhythms in middle-aged and older adults are associated with significantly faster shrinkage in key brain regions over time. The study is described as the first to directly link circadian rhythm quality with longitudinal changes in brain volume, adding to mounting evidence that circadian disruption is an upstream driver of neurodegeneration. Scientists say preserving circadian robustness through consistent sleep-wake scheduling and morning light exposure is emerging as a preventable risk factor for structural brain aging.

📌 Read more → Johns Hopkins Bloomberg School of Public Health

📌 TODAY’S TOP TAKEAWAYS

1. 🫀 Thymus as Longevity Organ: AI analysis of CT scans across 25,000 adults finds that healthy thymus tissue predicts a 50% lower risk of all-cause death and 63% lower cardiovascular death risk, reframing this overlooked organ as a modifiable longevity target.
2. 🧠 Cognitive Disability Rising Fast in Young Adults: Self-reported cognitive disability in US adults under 40 has nearly doubled since 2013, making younger adults the primary driver of overall cognitive impairment for the first time on record.
3. 🖨️ Adhesive-Free Wearable Tracks Metabolism Continuously: A 3D-printed University of Arizona device, published in Nature Communications on May 10, monitors dehydration, metabolic shifts, and stress through skin gas emissions with no adhesive and no skin irritation.
4. 💊 Eli Lilly Goes All-In on AI Drug Discovery: A $2.75 billion deal with Insilico Medicine signals that Big Pharma has moved from piloting AI to fully integrating AI-first companies as primary R&D partners.
5. ⏱️ Fasting Windows Alone Do Not Boost Metabolism: A controlled study finds that intermittent fasting without calorie reduction produces no measurable metabolic or cardiovascular benefit, confirming that caloric balance, not timing alone, is the key driver.

Sources compiled from Neurology, Neuroscience News, Scientific American, Stanford Medicine, Mass General Brigham, Nature, ScienceDaily, Cornell Chronicle, npj Aging, ACS Pharmacology and Translational Science, CNBC, The Medicine Maker, Nature Communications, Nature Medicine, The Washington Post, PNAS, Current Developments in Nutrition, University of Maryland School of Medicine, Johns Hopkins Bloomberg School of Public Health. Published: May 10, 2026.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.